MSTR vs. NVO
MSTR (Strategy Inc) and NVO (Novo Nordisk A/S) are both stocks. MSTR operates in Software - Application (Technology), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, MSTR returned 18.32%/yr vs 8.17%/yr for NVO. At a 0.18 correlation, their price movements are largely independent.
Performance
MSTR vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MSTR achieves a -39.01% return, which is significantly lower than NVO's -1.67% return. Over the past 10 years, MSTR has outperformed NVO with an annualized return of 18.32%, while NVO has yielded a comparatively lower 8.17% annualized return.
MSTR
- 1D
- 12.60%
- 1M
- -41.74%
- YTD
- -39.01%
- 6M
- -40.36%
- 1Y
- -75.86%
- 3Y*
- 39.36%
- 5Y*
- 6.88%
- 10Y*
- 18.32%
NVO
- 1D
- 0.56%
- 1M
- 6.06%
- YTD
- -1.67%
- 6M
- -2.80%
- 1Y
- -26.15%
- 3Y*
- -13.58%
- 5Y*
- 5.11%
- 10Y*
- 8.17%
MSTR vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MSTR Strategy Inc | -39.01% | -47.53% | 358.54% | 346.15% | -74.00% | 40.13% | 172.42% | 11.65% | -2.70% | -33.49% |
NVO Novo Nordisk A/S | -1.67% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between MSTR and NVO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 1998 | 0.18 |
Fundamentals
MSTR:
$30.95B
NVO:
$215.05B
MSTR:
-$39.78
NVO:
DKK 27.42
MSTR:
58.70
NVO:
4.30
MSTR:
0.84
NVO:
6.95
MSTR:
$490.47M
NVO:
DKK 327.80B
MSTR:
$334.08M
NVO:
DKK 268.30B
MSTR:
$466.93M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MSTR vs. NVO — Risk / Return Rank
MSTR
NVO
MSTR vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Strategy Inc (MSTR) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MSTR | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.52 | ||
| Sortino ratioReturn per unit of downside risk | -1.72 | ||
| Omega ratioGain probability vs. loss probability | 0.78 | 0.94 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | -0.93 | -0.53 | -0.39 |
| Martin ratioReturn relative to average drawdown | -1.37 | -0.84 | -0.53 |
Loading charts...
Drawdowns
MSTR vs. NVO - Drawdown Comparison
The maximum MSTR drawdown since its inception was -99.86%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for MSTR and NVO.
Loading charts...
Drawdown Indicators
| MSTR | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.86% | -74.70% | -25.16% |
Max Drawdown (1Y)Largest decline over 1 year | -81.95% | -49.17% | -32.78% |
Max Drawdown (3Y)Largest decline over 3 years | -82.63% | -74.70% | -7.93% |
Max Drawdown (5Y)Largest decline over 5 years | -84.11% | -74.70% | -9.41% |
Max Drawdown (10Y)Largest decline over 10 years | -89.27% | -74.70% | -14.57% |
Current DrawdownCurrent decline from peak | -80.44% | -64.87% | -15.57% |
Average DrawdownAverage peak-to-trough decline | -86.44% | -17.83% | -68.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 55.19% | 31.10% | +24.09% |
Volatility
MSTR vs. NVO - Volatility Comparison
Strategy Inc (MSTR) has a higher volatility of 28.41% compared to Novo Nordisk A/S (NVO) at 11.68%. This indicates that MSTR's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MSTR | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.41% | 11.68% | +16.73% |
Volatility (6M)Calculated over the trailing 6-month period | 60.21% | 37.71% | +22.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 74.35% | 51.65% | +22.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.65% | 38.48% | +52.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.13% | 32.57% | +41.56% |
Dividends
MSTR vs. NVO - Dividend Comparison
MSTR has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.73%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MSTR Strategy Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 3.73% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
MSTR vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Strategy Inc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MSTR and NVO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MSTR has higher volatility (28.41%) compared to NVO (11.68%). In terms of maximum drawdown, MSTR dropped -99.86% vs NVO's -74.70%.
NVO currently has the higher Sharpe Ratio (-0.51 vs -1.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MSTR and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer